RHYTHM PHARMACEUTICALS, INC. ($RYTM)
Filing Information
| Accession Number | 0001649904-26-000023 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 1, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
177,148
Total Value
$8,094,766.13
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Aug 31, 2026 | Exercise/Conversion | 57,187 | $25.79 | $1,474,852.73 | 176,798 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Aug 31, 2026 | Sale | 23,072 | $104.59 | $2,413,033.57 | 153,726 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Aug 31, 2026 | Sale | 11,514 | $105.37 | $1,213,232.48 | 142,212 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Aug 31, 2026 | Sale | 28,188 | $106.20 | $2,993,647.35 | 114,024 | Direct | โ | View Details | |
Chief Financial Officer | Employee Stock Option (Right to Buy) | Derivative | Aug 31, 2026 | Exercise/Conversion | 57,187 | $0.00 | $0.00 | 3,813 | Direct | โ | View Details |